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INTRODUCTION 
 
 HIV has evolved form a mysterious illness to global pandemic which 
has infected tens of million in 20 years. 
 
 By December 2003, 40 million people were living with HIV /AIDS. 
According to UNAIDS, WHO, (2003)1, people newly infected with HIV were 
about 5 million in 2003, and about 3 million AIDS death in 2003. In SEAR 
countries according to WHO, reported HIV infection around 46.5 million and 
AIDS can as around 2.67 as May 20032. 
 
 The HIV epidemic in India in the early ascending phase with the total of 
5 million HIV cases3. In India the first HIV seropositive case was identified in 
Madras and the first AIDS case in 19863. 
  
According to NACO, 2004 the cumulative number of AIDS case in 
India has risen to 86028 no August 31st 2004. Another 7799 new cases of 
AIDS were detected in the month of August 2004. 
 
 Overall prevalence is around 0.7% in India. Tamilnadu has the 
prevalence of 1.35 to 1.50% and Maharastra has the prevalence of 1.50 to 1.75. 
By mid 2003, Tamilnadu had nearly half the reported AIDS cases (about 47%) 
Mumbai and rest of Maharastra now share about 21% of reported cases of 
AIDS4. 
 
 According to AIDS sentinel surveillance 2003, males account for 73.5% 
case of AIDS cases and females 26.5%. Since majority of HIV infections 
(27.7%) are in the age group of 15-44 years out of which 35% in the age group 
of 15-24 years, which implies it carries a greater social burden to the country. 
 
 In HIV infected patient progressive decline in their immunological 
response makes them extremely susceptible to various opportunistic infection 
and is the presenting symptom in approximately a third of HIV positive 
patient3.  
  
 Opportunistic infections pose threat to life of AIDS patient. Proper 
detection and management with the antiretroviral therapy changes the HIV 
once dreadful disease to chronic manageable disease. 
 
 Of the number of cases detected for opportunistic infection during 2003, 
Tuberculosis around 3572 cases, PCP around 2130 cases, Herpes around 431 
and cryptosporidiosis around 130, toxoplasmosis around 75 and the rest others. 
Intestinal parasites emerge as one of the important opportunistic infection.  But 
there exists significant geographical variation in the prevalence of intestinal 
parasitic infection in HIV patient. 
 
 Diarrhoea is a common complication of HIV positive patient. It occurs 
in almost 90% of AIDS patients in developing countries. 
 
 According to AIDS surveillance case definition, Center for Disease 
Control, Atlanta, Chronic intestinal cryptosporidiosis > 1 month duration and 
chronic intestinal isosporidiosis, > 1 month duration, were included in category 
C, so it is imperative that detection and treatment of diarrhea may increase the 
quality of life with HIV infection5. Chronic diarrhea is found to be an 
independent predictor of morality in AIDS6,7. 
 
  
AIM OF THE STUDY  
1. To study the prevalence of intestinal parasites in HIV patients with and 
without Diarrhoea. 
 
2. To study the correlation between CD4 counts and the intestinal parasites. 
REVIEW OF LITERATURE 
History 
The first indication of new syndrome came in 1981, with reports form 
USA of a sudden unexplained outbreak of two rare disease Kaposi sarcoma 
and Pnemocystic jerovici in young adults who were homosexual and addicted 
to narcotics. The conditions was given the name acquired immune deficiency 
syndrome. 
 
In 1983, Luc Mantagnier and Colleague from Pasteur institute Paris 
isolated the virus and called in LAV. In 1984 Robert Gallo from National 
Institute of Health, USA named HTLV III. 
 
 In 1985, Elisa available for defection of anti HIV anti bodies. In 1986 
international committee on virus nomenclature decided on the generic name of 
human immuno deficiency virus (HIV). 
 
Epidemiological Features: 
 India is epidemic is marked by heterogenicity, not by single epidemic 
but made up of number of distinct epidemis in some places in some state. In 
India epidemic seems to be following type 4 pattern, that epidemic spread form 
highest risk group (commercial sex workers, homosexual men, drug users) to 
bridge population client of sex workers, migrant population and then to general 
population. This shift usually occurs where prevalence of first group reaches 
5%. 
 
 Based on sentinel serveilliance data, HIV prevalence classified as  
 
Table No.1 : Prevalence status  
Group Prevalence High Risk Group Antenatal mother 
I High > 5% > 1% 
II Moderate > 5% > 1% 
III Low < 5% < 1% 
 
I Group:  States like Maharastra, Tamilnadu, Karnataka, Andrapradesh,  
Manipur, Nagaland.  
II Group:  States Goa, Pondicherry,  
III Group:  Other states. 
Agent Factors: 
 HIV belongs to the lentivirus subgroup of the family retroviridae, which 
is a spherical enveloped virus about 90-120 nm in size. The nucleocapid has an 
outer icosahedral shell and inner cone shaped core enclosing 
ribonucleoproteins outer shell enclosing two glycoprotein  gp 120, the external 
glycoprotein and gp 41, the trans in membrane glycoproteins. 
 
 
 
Host Factor: 
 
 Age: Most case occurs among the sexually active persons. In India 
87.7% are in age group of 15.44 years, out of which 35% in the age group of 
15-24 years. 
 
 Sex: In India males have higher proportion, but in Africa the sex ratio is 
equal.  
 
High Risk groups: 
 Male homosexual and bisexuals, heterosexual parters, (including 
prostitues, intravenous drug abusers, transfusion of blood and blood products.  
 
Domicile: 
 The trend of transmission shows infection spreading from urban to rural 
areas.  
 
Replication Cycle of HIV 
Attachment and entry: 
 GP 120 which after binds to N terminus of the receptors CC_R5 and    
CXCR4, on the host cell surface CD4 molecule. GP 120 undergoes (molecule) 
configurational changes which makes easy way for the penatraions of GP 41. 
Reverse transcription and integration 
Binding to CD4 molecule, virus is uncoated and the viral RNA is 
transcribed by enzyme reverse transcriptase into first single stranded DNA then 
to double stranded DNA which is integrated into host cell chromosome. 
 
Transcription, Translation and Replication: 
 The integrated DNA is transcribed into messenger RNA (MRNA) which 
comes out to cytoplasm and viral proteins are synthesized using protein 
synthesing machinery and raw material from the host cell. 
 
Maturation and release: 
 Newly synthesized progeny RNA and proteins are packaged together 
and released from the infected cell by “budding”. 
 
Pattern of Transmission: 
 It is summarized in the following table. 
 
 
 
 
Table 2: Exposure and Transmission Rate 
Types of Exposure Percentage Global Total In India 2004 
Sexual  
Vaginal 
Anal 
 
70-80% 
5-10% 
 
85-72% 
 
Perinatal 5-10% 3.14% 
Injection Drug use 5-10% 2.95% 
Blood transfusion 3-5% 2.17% 
Others not specific 1-2% 6.02% 
 
 Estimates per contact risk of HIV infection is summarized in the 
following table. 
Table 3: Actual risk per contact. 
Activity Risk 
Needle Sharing 6/1000 to 30/1000 
Occupational Needle Stick 1/300 
Receptive Anal Sex 8/1000 to 30/1000 
Receptive Vaginal Sex 3/10000 to 10/10000 
Receptive Oral Sex:  Unknown 
* Source: www. Cambridge.org.  Adapted from table 1-2, Libman H, Makadon 
HJ, HIV therapy series, American college of physician, Philadelphia 2003. 
 Approximate chance of infection per exposure to blood and blood 
products is >90% and mother to baby transmission is around 30%. 
 Molecule Epidemiology of HIV: 
 According to sequence analysis gag and env genes, HIV 1 is classified 
into 10 subtypes from A to J which constitutes group ‘m’ (major) group ‘o’ 
(outlier) which constitutes  heterogenous group and group N (new) is isolated 
from comeroon. Of the subtype in India, A and C is the most prevalent, 
worldwide subtype A is the most prevalent, B is more common is Africa and 
Europe. 
 Atleast 5 types of HIV-2, which is prevalent in Africa and India. HIV -2 
has only 40% genetic homology with HIV-1. 
 
Molecular Genetics 
 HIV contains gene which code for structural, non structural and 
regulatory proteins. Of the genes ‘gag’ genes determines core and shell, ‘env’ 
gene determines the synthesis of gp 160 which cleaves into two glycoproteins, 
gp 120 and gp 41. ‘pol’ gene determines the polymerase protein of the non 
structural gene ‘vpu’ present only in HIV-1 and ‘vpx’ gene present only in 
HIV-2. 
 
Progression of Illness: 
 
 Average period to develop AIDS is 8-10 years. 5-10% of infected 
people progress to AIDS with in 2-3 years, they are called rapid progressors. 
About 5% of infected people do not progress to AIDS even after 10 years are 
called long term non progressors. The reasons are  
 
1. Mutant nef gene of HIV 
2. Defective CCR5 cobinding protein on the macrophage due to genetic 
abnormality in the patient (10) 
 
CLASSIFICATION 
 Revised classification system for HIV infection and expanded AIDS 
surveillance case definition for adolescents and adults (CDC – Atlanta) -1993. 
Table 4: Classification of HIV 
CLINICAL CATEGORIES  
A B C 
CD4+ Cell count (per 
milcrolitre)conditions 
Asymptomatic, 
acute primary 
infection or PGL 
Symptomatic but 
not A or C 
conditions 
AIDS indicator 
> 500 A1 B1 C1 
200 - 499 A2 B2 C2 
< 200 A3 B3 C3 
 
HIV infected persons classified in A3, B3, C1, C2, c3 are AIDS cases. 
1993 AIDS surveillance case definition CDC Atlanta: 
 One or more of the following conditions in an adolescent (>13 years of 
age) or adults 
Asymptomatic HIV infection 
1. PGL 
2. Acute (Primary) HIV infection with accompanying illness or history of 
acute HIV infection. 
Category B: 
Symptomatic conditions in a HIV infected adolescent or adult that are 
not included in clinical categorty ‘C’ and that meet atleast one of the following 
criteria. A)The conditions are attributed to HIV infection or are indicative of a 
defect in CMI. B) The conditions are considered by physician to have a clinical 
course or to require management that is complicated by HIV infection. 
1. Bacillary angiomatosis 
2. Bulvo vaginal candidiasis (Persistent, frequent or poorly responsive), 
oral candidiasis 
3. Cervical dysplasia, cervical carcinoma in sity 
4. Constitutional symptoms lasting more than one month 
5. Oral hairy leukoplkia 
6. Herpes zoster involving atleast 2 distinct episodes ormore than one 
dermatome 
7. Idiopathic thrombocytopenic purpura 
8. Listeriosis 
9. Pelvic inflammatory disease 
10. Peripheral neuropathy 
Category C: 
AIDS Indicator conditions  
1. Candidiasis of the bronchi, trachea or lungs  
2. Oesophageal candidiasis  
3. Cervical cancer – invasive  
4. Coccidioidomycosis  
5. Cryptococcosis – extra pulmonary  
6. Cryptosporidiosis – Chronic intestinal (>one month duration) 
7. Cytomegalovirus disease (other than lung, spleen and nodes) 
8. Cytomegalovirus Retinitis (with loss of vision) 
9. HIV related encephalopathy  
10. Herpes simplex – chronic ulcer, bronchitis, pneumonia or oesophagitis  
11. Histoplasmosis – disseminated or extra pulmonary  
12. Isosporiasis – chronic intestinal (>one month duration) 
13. Kaposi’s sarcoma  
14. Burkitt’s lymphoma  
15. Immunoblastic lymphoma  
16. Primary brain lymphoma  
17. Mycobacterium Avium Intracellulare Complex, M.kanasasii infection – 
disseminated or extra pulmonary. 
18. M.tuberculosis – any site  
19. Mycobacterium other species or unidentified species – disseminated or 
extrapulmonary  
20. Pneumocytis carinii pneumonia  
21. Recurrent pneumonia  
22. Progressive pneumonia  
23. Progressive multifocal leukoencephalopathy  
24. Salmonella septicaemia – recurrent  
25. Toxoplasmosis of brain  
26. Wasting syndrome 
 
Intestinal Parasitosis in HIV Patinets 
Broadly classified as  
1. Protozoa  1. Cryptosporidium. Parvum  
  2. Isospora belli, Hominis  
  3. Entamoeba Histrolyrica 
  4. Entamoeba coli  
  5. Giardiasis 
Cestodes : 1. H. nana  
 
2. Namatode   : 1. Ascaris lumbricoids 
    2. Ankylostoma deodenable 
    3. Trichuris Trichuria     
3. Trematodes  : No significant percentage seen. 
 Cryptosporidiosis in HIV patients 
Incidence :- 
 Incidence of Cryptosporidiosis in HIV patients with diarrhoea varies 
geographically from 10 to 20% in united state and western Europe to as high as 
50% in developing countries9. 
Agent Factor:- 
 Cryptosporidiosis parvum occyst appeared as pinkish or orange 
spherical bodies measuring 4-6µm. 
Transmission:- 
 Although most case occurred in immuno deficient patient, it also cause 
self limited gastroenteritis most of transmission attributed to contamination in 
water supplies10, 11, swimming pools12 and even in hospital ice machines13.  
 
Clinical Manifestations:- 
 Although cryprosporidosis can be acquired any time during the course 
HIV infection14, major morbidity and mortality occur almost exclusively in 
patients with CD4 counts below 180cells/ mm3, above this level spontaneous 
recovery generally occurs10. Patient with CD4 counts <50 cells/mm3 usually 
results in progressive diarrhoea. Cryptosporidiosis mainly leads to chronic 
malabsoption of fluids, nutrients, Vitamins and electrolytes which results in 
wasting and hypokalemic metabolic acidosis15. In patient who fail to respond 
to therapy, death usually occur in 3 to 6 months16. 
 
 The most common clinical manifestation of cryptosporidiosis is an acute 
onset, non bloody diarrhoea without fever. Temperature higher than 39C is 
not characteristic of cryptosporidiosis and warrents investigation of other 
infection. Patient with AIDS have voluminous diarrhoea even upto 17 litre/day. 
Gastric involvement may present as nausea and vomiting without diarrhoea17. 
Pathophysiology   
 Cryptosporodiasis clinically present as  
1. Transient (28.7%) 
2. Chronic (59.7%) 
3. Fulminant (17.8%) 
4. Asymptomanc (3.9%) 
Fulminant cryptosporidiosis means passage of more than 21 stools / 
day. 
Pathogenesis 
 In HIV infected individuals lack of cell mediated immunity leads to 
heavy infestations of cryptosporidia oocysts on the intestinal mucosa, and these 
infestations correlate with an intense inflammatory response and impaired 
absorptive function18, 19. The mean infective dose is 132 oocysts in non 
immune persons. 
 
Preventive medicine: 
     After the 4 lakh cases of cryptosporidiosis in Milwakee, Wilconsin in 1993, 
resulted in atleast 100 death in patient with AIDS. Mortality is 73% in CD4 
counts less than 50 cells/mm3 and 86% when baseline count was between 50 to 
200 cells/mm3, it is clear that HIV patients are at risk. 
 
 Chlorination is not effective in preventing cryptosporidiosis but 
ozonation may be effective23. 
 
 Centre for disease control, Atlanta made these Recommendations in 
prevention of cryprosporidiosis in HIV patients23, 24. 
 
1. HIV patient should not drink water directly from lakes and ponds. 
2. They should avoid ingesting even small amounts of swimming pool 
water  
3. Person with cryptosporidium should not use swimming pools. 
4. Boiling tap water or filtering it through one micron filter or by using 
bottled filtered water will decrease the exposure. 
5. Because substantial variation in purity exists among bottled water, water 
that comes from underground springs or that has filtered through NSF 
standard #53 filter will remove the oocystes.  
Isospora belli : 
 Oocysts appears as oval bodies with immature or mature sporocyst 
measuring 20-40mm. Higher rates of isosporodiasis reported from Brazil in 
AIDS patient. The lower prevalence of isosporodiasis is ascribed to secondary 
prophylaxis for pnemocystosis through administration of sulfamethoxazole – 
trimethoprim during the course of infection, since is isopora belli is sensitive to 
this treatment. In HIV patient, isospora belli present with Loose motion, fever, 
intestinal colic, abdominal pain, loss of weight and Biliary colic. 
 
E.HISTIOLYTICA: 
Intestinal infection quite common among homosexuals studies in north 
America and Europe showed 20-30% of homosexual were positive for E. 
Histiolytica  in their stool specimens. In Brazil the prevalence of amoebic 
infection in HIV is 5.8%. Presence of trophozoites in fresh stool is 
pathognomic. Clinical presentation of the patients were similar to that reported 
in non HIV patients. 
 
 
HIV and Other Helminths: 
 The more common pathogenic helminth associated with AIDS is 
strongyloides stercoralis. Other helminth reported were Ascaris lumbricoides 
(3-5.2%), Trichuris Trichuria 4.14%, Ankylostoma deodenale (2.69%) 
Schistosoma mansoni (1.66%), H.nana (10.41%) 
 
 Co infection of HIV and round worms is particularly important. Adult 
round worms resides in the small intestine, but larvae migrate through tissues. 
Ascaris polarizes the immune response in young adults to Th2, which increases 
the risk of sexual transmission of HIV. 
 Ascaris also suppress interleukin 2, a Th 1 cytokine that can be use for 
AIDS/HIV because it improves count of CD4 + T cells and restores immune 
function substantially 
HIV and Giardiasis: 
        Giardia lamblia, infection is very commonly found in HIV patients with 
increased viral load. Though the same occur in Immuno competent person, in 
presence of HIV, they can cause severe prolong refractory diarrhoea. 
HIV and other Parasites  
 Microsporidiasis are present with chronic diarrhoea and with billary 
manifestation with HIV and in infected individuals with CD4 counts between 
50-100/mm3.  
 Cyclospora, Blastocystis hominis are also reported in HIV patients with 
diarrhoea.  
Role of ART  
 It is found that treatment with ART can clear cryptosporodiasis from an 
individual by reconstitution of immune system (WWW.Stanford.edu.) Other 
drugs like Paramomycin, Azithromycin found to be moderately effective 
against cryptospordiasis Nitazoxinide is effective in those who were not 
respond to the above drugs. 
MATERIALS AND METHODS 
Setting: 
 
   The study was conducted in both in patients and outpatients of Govt 
Rajaji Hospital.  
Collaborating Departments:   
1. ICMR / Out Patients 
2. ART / Out Patients 
3. Department of Medicine / In Patients 
4. Institute of Microbiology, MMC, 
Madurai. 
 
Design of study: Prospective analytical study  
Study period: A period of 13 months from Jan 2005 to Feb 2005. 
Sample Size:  
 120 patients with AIDS were included in the study.  40 patients of non 
diarrhoeal healthy HIV negative family members were included as control.  Among 
the 80 patients with diarrhoea, patients were grouped based on clinical profile 
diarrhoea, as those with diarrhoea less than 2 weeks and those with more than 2 
weeks. 
Ethical Clearance: Obtained 
 
 
Consent:  
       An informed consent were obtained from each patient. 
Definition: 
Diarrhoea is defined as passage of abnormal liquid or unformed stools in 
increased frequency.  Diarrhoea may be further defined as acute if less than 2 
weeks, persistant  if 2 to 4 weeks and chronic if greater than 4 weeks.  In our 
study diarrhoreal groups were classified as those who were presented with 
diarrhoea less than 2 weeks and those with greater than 2 weeks. 
 
Selection criteria’s 
Inclusion Criteria      
1. All men and women who were positive for HIV by Elisa who presented with 
and without diarrhoea were included in the study. 
2. Of the 120 total patients more than 15 years of age group of patients were 
selected. 
 
EXCLUSION CRITERIA  
Patients who were excluded from the study like  
1. Endocrine disorders 
2. Malignancy   
3. Collagen vascular disorders 
4. Other organ disorders. 
5. Patients on steroids therapy  
6. Pregnancy  
7. Tobacco and alcohol user. 
8. Protein losing enteropathy 
9. Crohn’s disease 
10. Irritable bowel syndrome 
11. Unconscious / Bed ridden 
12. Non co-operative non-willing 
13. who were on antidiarrhoeal or on antimotility drugs 
14. Patient using liquid paraffin / laxatives 
15. Patient subjected to barium or Bismuth salts during the last one week 
16. Tuberculosis 
17. Renal disorders 
18. Cholestasis 
 
Materials:   
Data Collection 
 Socio demography / clinical data were collected.  They were subjected to HIV 
testing after proper counseling at voluntary confidential counseling and testing centre 
of this hospital.  Blood samples were collected for Elisa for HIV-1 and HIV-2 using 
Innotest TM HIV-1/HIV-2 Sp innogenetics, N.V. Belgium , and lab systems HIV 
EIAKIT Finland, Elisa was done using the above two different kits. 
 Patients were explained about the proposed study and asked to collect 
stool samples. 
Stools were subjected to the following methods for evaluation of 
parasites. 
1. Wet saline method 
2. Wet Iodine method 
3. Floatation technique  
4. Sedimentation technique  
5. Modified Acid fast technique. 
 
Collection of stool: 
 For stool sample collection essentials criteria followed were : 
1. Fresh  stool samples 
2. Receptacle was kept clean and without antiseptics. 
3. Patients were instructed not to mix urine with stool. 
Samples were taken to the microbiology department, within 30 minutes. 
Preparation of Materials:  
  Two smear preparation; one unstained preparation and another stained 
with Iodine were made out.  
 
 
a) Wet Saline Method 
Minute position of faces is diluted with normal saline 0.9% and a 
drop of it is taken on a clean microscopic glass slide. A coverslip No 1 
or No 0 is then gently put over it to spread out the emulsion. Unstained 
preparation is specially useful for demonstration of actively motile 
forms of parasites like E. histolytica. 
b) Stained Preparation: 
Staining done by Lugolis Iodine by schaudinn’s fluid for permanent 
preparation.  Parasites were evaluated using conventional simple light microscope 
(NIKON). 
c) Floatation technique:- 
Fecal materials were dissolved in a solution which has higher 
density than eggs and hence floatation of egg useful in detecting parasites.    
d) Sedimentation technique:- 
 Fecal material were dissolved in solution of density below that of 
eggs. So egg will be concentrated at the bottom.  
1. Formal ether saline (Ritchell’s method modified) and Formol ether I2 
methods were used. 
e) Modified Acid Fast Staining Method:- 
 It was adopted to detect cryprosporidiosis and isosporodiosis.  The 
details are given below. 
Preparation of smear 
1) With Diamond pencil write lab no were written in full one glass 
slide for each specimen. 
2) Using 5mm internal diameter 24 SWG Nichrome  wireloop 
smear were prepared with a portion of thickest part on about 2/3rd of 
slide. 
3) Slides were air-dried. 
4) The slides were transferred to hot plate 80oC and were fixed for     
10 mts. 
 
Staining: ‘Kinyoun’ staining 
 This staining technique was adopted for Acid Fast Staining method. 
 
1) The slide were placed on staining track with the smear part upper 
most, the slides not touching each other. 
2) The slides were covered with carbol fuchisn stain, leave for 1 – 10 
minutes. 
3) With running tap water, the slides were washed well with water.   
4) Slides were decolourized by covering completely with acid alcohol 
for 1-2 minutes. 
5) Slides were washed again gently with running tap water. 
6) Slides were counterstained with 1% methylene blue for 30 sec. 
7) Slides were wash as before with water and the  slides were  sloped  
on hot plate and smear were read. 
Cryptosporidium appeared as round or oval shaped pink coloured  
oocysts measuring 4 – 6 µm. 
Isospordium appeared with mature or immature oocysts measuring            
20-40 µm. 
 
CD4 Count: 
Method of collection for CD4, CD8 and CD4/CD8 ratio was as 
described below. 1ml of Blood was taken in the morning to avoid diurnal 
variation in a special tube (vacutainer) containing K3 EDTA solution and was 
thoroughly mixed and immediately transported under room temperature 
without refrigeration as it was falsely increases the count. 
 
CD4, CD8 ratio were done by immuno cytometry using. Becton 
dickinsin immuno cytometry system. There is substantial variation in CD4 cell 
counts attributable to counting technique, diurnal and seasonal variations, use 
of drugs like steroids and possibly other factors like intercurrent illness. The 
values which is the product of WBC, percentage of lymphocytesand the 
percentage of lympocytes that expressed on the CD4 membrane. 
 
In order to reduce variability, each test should be done at approximately 
the same time of day using a single laboratory. Large fluctuation may reflect 
the technology of test rather than the biology of the disease. Overall trend of 
CD4 count is more important than any single value. 
 
Guidelines recommended by CDC, USA (MMWR 41, RR 8, 1992) were 
adopted to estimate the CD4 and CD8 count.  It recommends that, 
 (i) hematological test should be performed with in 6 hours.                 (ii) 
automated lymphocyte count should be done (iii) Immuno phenotyping should 
be done within 30 hours and (iv) a monoclonal antibody panel should be used 
that will account for all lymphocytes in the sample as an internal control; an 
abbreviated panel may be used for sequential follow up. 
 
 There are substantial diurnal changes with a nadir at 12.30 pm and peak 
at 8.30 pm. Seasonal month to month changes are also seen in healthy adults. 
Acute administration of steroid may cause profound decrease in CD4 count.  
 
 
Analysis: 
  Data were entered in Microsoft Excel Spreadsheet and were analysed 
using statistical package.  
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Limitation of the study: 
1) Infective status of the parasitic infestations were not confirmed by 
serological studies. 
2) Re-evaluation of the negative cases was not attempted22. 
3) Therapeutic aspects of those cases with intestinal parasitosis were not 
brought out. 
4) Post ART follow up of the cases receiving ART was not analysed in 
relation to non ART cases. 
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of which E.Histolytica were found in 48 patients (12.77%), E.coli were 
found in 46 patients (12.23%), Giardia  were found in 39 patients (10.37%) 
D. Fragilis in 23 patients (6%), cryptosporidiosis were fount in 11 patients 
(3%) and isospora belli in 4 patients (1%). There is significant correlation 
between  cryptosporidiosis and diarrhoea when CD4 count is below 200 
cells/mm3. 
   
2) Coppola MD, Romana J, Altiers, Intestinal Parasitosis from 1992 to 
1995; www. Nebi.nlm.nih.gov/ 
 
Out of 1200 patients studied 703 patients were HIV negative and 
497 were HIV postive. Of which 203 patients with symptoms of diarrhoea 
from the study Giardiasis were found among the HIV negative patients and 
cryptosporidiosis found mainly in HIV positive patients. According to the 
study cryptosporidiosis were found in 54 HIV positive patients and only in 
3 HIV negative patients. 
 
3) Ebba Abate, Endris Mekonnen, Journal of Ethiopian medical Practice, 
Volume 3: No:2 (2001). 3:2 – 64-69. 
Of the 100 patients studied 50 patients were HIV positive and 50 
patients were HIV negative. Of them cryptosporidiosis were found among 
17% of Hiv patients and 2% of isospora belli were found and 48% of 
infection were mixed one. Of which cryptosporidiosis were significantly 
associated with HIV positive patients.  
 
4) Brandonsio. O, P.Maggi, G. Angarano et al. Prevalence of 
cryptosporidiosis in HIV infected patients with diarrhoea. European 
Journal of Epidemiology 9:2:190-194. 
According to the study 51 HIV positive patients presents with 
diarrhoea were included of which 17 cases of cryptosporidiosis were 
reported (33.7%). 
 
5) Alijandro Carabello, Indhira Ozozco, Bol.Chil Parasitol intestinal 
parasitic infection in HIV positive individuals in south eastern 
Venezuela. 
 
According to this study cryptosporidiosis were found in 22.8%, 
Ascaris lumbricoides in 14.2%, Hookworm in 8.6% and trichuris trichuria 
in 8.6%, I. belli in 2.9%. According to htem 56.5%, cryptosporidiosis is 
found and CD4 count <200 cells/mm3 and 32% between 200-500 cells/mm3 
and 12% when CD4 count above 500 cells/mm3 E.Histolytica were found 
in 28.9% when CD4 <200 cells /mm3 and 17.4% when CD4 count between 
200-500 cells/mm3 and 53.7% when CD4 count above 500 cells/mm3.        
   
6) Kava Mohandas, Rakesh sengal, Prevalence of Intestinal parasitic 
pathogen in HIV positive patients in northern India. Jpn, J. 
Infect.2002.Dis :55: 83-84. 
 
Out of 120 HIV positive patients 36 patients were infected with 
intestinal parasites, out of which 21 patients were associated with diarrhoea.       
 
Cryptosporidiosis were found in 10.8% of which 92.3% were 
presented with diarrhoea. Giardia 8.3%. Isospora belli 3% and E.Histolitica 
2.3%.  
 
RESULTS 
 
 
The observations made in the study are tabulated and described under: 
 
 
1) Sex 
 
 Among 120 patients studied 62 were males and 38 were females.  In this study 
male and female do not differ with regard to HIV status or the presence or absence of 
diarrhoea.  The details are given in the Table 1 below. 
 
 
Table 1: Distribution of cases and control in relation to the gender 
 
 HIV positive cases 
 With Diarhoea* With out 
Diarhoea 
Total 
HIV 
negative 
control 
Male* 41 21 62 20 
Female 39 19 58 20 
Total 80 40 120 40 
 
  
 * not significant    P value = 0.89722 
2) Age 
 Diarrhoea when analysed in relation to age group it was seen more among  
those below the age of 40 years than in those above 40 years and the difference was 
statistically significant.  At the same time it was independent of gender.  Details are 
shown in the table below. 
 
Table 2: Distribution of cases and control in relation to age 
Age 
group 
years 
 
HIV Positive cases 
 
HIV Negative 
control 
 With Diarhoea Without Diarhoea  
 Mal
e 
Female Total Male Female Total Male Female Total 
< 30* 9 15 24 6 5 11 7 7 
 
14 
 
31 – 40* 21 15 36 8 9 17 8 8 
 
16 
 
41 – 50 7 4 11 4 2 6 4 4 
 
8 
 
> 50 4 5 9 3 3 6 1 1 
 
2 
 
Total 41 39 80 21 19 40 20 20 
 
40 
 
* significant 
 
 
 
Distribution of cases and control in relation to age. 
 
Out of 120 HIV positive patients 71.8% were below the age group of 
40.  The age range of HIV patients varied from 20 to 57 years.  The mean age 
was 35.28 (SD ± 9.03).  There was no significant difference among gender 
with reference to the age.  The results are tabulated below: 
 
Table 3: Distribution of cases and control in relation to age. 
 
 
Male 
 
Percentage Female Percentage Total Percentage 
< 30 22 26.8 27 34.6 49 30.6 
 
31 – 40 37 45.1 32 41 69 
 
4.3 
 
41 – 50 15 18.3 10 12.8 25 
 
15.6 
 
> 50 8 9.8 9 11.5 17 
 
10.6 
 
Total  82    78  160 
 
100 
 
  
 
 
 
 
 
 3) Domicile Pattern 
 57.5% were resided in rural area and 42.5% were resided in urban area.  
Details are provided in the Table below. 
 
Table 4: Domicile Distribution 
 
 Male Female Total 
 
Rural* 
 
48 
(58.5% 
44 
(56.4%) 
92 
(57.5%) 
 
Urban* 34 
(41.5%) 
34 
(43.6%) 
 
68 
(42.5%) 
 
 
Total 82 78 160 
 
P value = 0.78566     * not significant 
 
4) Educational Status 
Out of 62 cases of HIV positive male patient 9.7% were illiterates, 
19.4% had primary, 29% had middle school, 35% had higher secondary 
school, 3.2% had college and 1.1% had technical education. Among the 
females 25.9% were illiterates and 29.8% had primary, 22.4% had middle 
school and 20% had higher school, none of the female had college education.  
Details are provided in the following table. 
 
Table 5:  Educational status of HIV patients 
 
 Male Percentage Female Percentage Total 
 
Illiterate 6 9.7 15 25.9 
 
21 
 
 
Primary 12 19.4 17 29.3 
 
29 
 
 
Middle 18 29.0 13 22.4 
 
31 
 
 
Higher 22 35 12 20.7 
 
34 
 
 
College 2 3.2 0 - 
 
2 
 
 
Technical 2 1.1 1 3 
 
3 
 
 
Total 62  58  
 
120 
 
 
 
 
  
5) Marital Status 
While majority 96.9% were married, only 3.1% were unmarried. 
6) Occupation 
Various occupational categories are noted.  They were agricultural, 
labourers, transport, crews, skilled worker, load men, and other.  Most of the 
women were unemployed. 
 
7) Sexual Behaviour 
Of the study group most of the men (91.2%) admitted promiscuous 
sexual behaviour, while 8.8% men and all women denied history of 
promiscuits. 
 
8) Housing Status 
 More than 80% of the rural people lived under thatched shed where as 
rest lived in concrete buildings. 
 
9) Water sources 
 Both cases and controls were depended on common water sources. 
 
10) Hand Washing 
 Irrespective of literacy status, hand washing habits and  other hygienic 
practices were far from satisfactory among cases and controls. 
 11) Clinical Examination 
 Most of HIV positive patients were emaciated with coated tongue and ill 
looking sunken eyes.  Most of them were dehydrated.   There were no pedal 
oedema.  Their vitals were stable and their urine output were satisfactory.  
Their cardiovascular, respiratory, central nervous system examination findings 
were normal.  There was no abdominal  distension and no abdominal mass. 
 
12) Diarrhoeal groups 
 In the present study diarrhoea was independent of  gender.  The results 
are tabulated below. 
 Table 6:  Distribution of cases in relation to diarrhoea and gender 
patients. 
Sex With Diarhoea Without Diarhoea 
 < 2 weeks* > 2 weeks Total  
Male* 19 22 41 
 
21 
 
 
Female 
 
20 19 39 19 
 
Total 39 41 80 40 
 * not significant                 P value = 0.65056 
 
Diarrhoea in relation to age  
Duration of diarrhoea was independent of distribution of age.  The results are 
tabulated below. 
 
Table 7: Distribution of diarrhoea in relation to age  
Age 
group 
years 
 
With Diarhoea 
 
Without Diarhoea 
 
< 2 weeks > 2 weeks  
 Male Female Total Male Female Total Male Female Total 
< 30 3 8 11 6 7 13 6 3 
 
9 
 
31 – 40 10 7 17 11 8 19 8 9 
 
17 
 
41 – 50 4 2 6 3 2 5 4 2 
 
6 
 
> 50 2 3 5 2 2 4 3 3 
 
6 
 
Total 19 20 29 22 19 41 21 19 
 
40 
 
 
P value = 0.303    Not significant 
 
13) CD4 Count 
CD4  status among the cases are  shown in the table given below: 
CD4 count / mm3 With diarrhoea* 
(N = 80) 
Without diarrhoea 
(N=40) 
Range* 28 – 881  36 – 830 
Mean 252.81 300.23 
SD 184.27 235.63 
* Significant 
Mean CD4 status those with diarrhoea was significantly lower than 
those without. 
Distribution of CD4 counts in HIV patients 
Irrespective of gender those who had diarrhoea, CD4 counts were lower. The 
distribution of CD4 in relation to gender and diarrhoea is shown in the table 9. 
Table 9: Distribution of CD4 counts in HIV patients 
 With Diarhoea Without Diarhoea 
 M % F % T % M % F % T % 
< 50 2 4.9 6 15.4 8 10 3 14.3 0  3 7.5 
51 – 
100 2 4.9 4 0.3 6 7.5 4 19 1 5.3 5 12.5 
101 – 
200 13 31.7 12 30.8 25 31.3 4 19 4 21.1 8 200 
201 – 
500 19 46.3 13 33.3 32 40 6 28.6 10 52.6 16 40 
> 500 5 12.2 4 10.3 9 11.3 4 19.0 4 21.1 8 20 
Total 41  39  80 100 21  19  40 100 
 
10) Distribution of parasites among cases and control are provided below 
table no.10 
Table 10: Distribution of parasites among cases and control 
 Intestinal 
parasites 
With 
diarhoea 
Without diarhoea Control 
     
1 Crypto 10 2 2 
2 E.Histo 6 3 2 
3 E Coli 7 2 3 
4 Ascaris 4 3 3 
5 H.nana 1 0 1 
6 Ankylostoma 1 1 1 
7 Giardiasis 1 2 3 
8 Mixed 13 0 1 
  43 13 16 
P =  0.10214 
* Statistical significance  could not be  assessed as the numbers are low. 
 
Analysis of Intestinal parasitosis is provided in the table 11, in relation to 
diarrhoea. 
 
Table 11: Prevalence in internal parasites in the study group. 
 HIV +ve 
 With D 
Without 
D 
Total % HIV -ve Total % 
Crypto 21 2 23 19.2 2 25 27.5 
E.Histo 16 2 18 15.0 3 21 23 
E.coli 12 3 15 12.5 3 18 19.7 
Ascaris 6 3 9 7.5 2 11 12.1 
H.nana 1 0 1 0.8 1 2 0.02 
Giardiasis 3 2 5 4.2 4 9 0.09 
Ankylostoma 2 1 3 2.5 1 4 0.04 
Isospora 1 0 1 0.8 0 1  
 62 13   16 91 100 
 80 40 120  40   
 
Some of them had more than one organisms in their stools.  Overall 
parasitic infestation was significantly more among HIV positive group.  
Commonest parasitosis among HIV postive group were cryptosporidium 
(19.2%), followed by E.Histolytica (15%), E.coli (12.5%) ascaris (7.5%), 
H.nana (0.8%), Giardiasis (4.2%), Ankylostoma (2.5%) and Isospora (0.8%).  
Of the HIV positive patients 62 of 80 (77.5%) had diarrhoea where as it was 13 
of 40(16.2%) non-diarrhoea. 
Distribution of cases in relation to CD4 and cryptosporidiosis is provided 
in table 12. 
Table 12:  Distribution of cryptosporidiosis and CD4 count  
 
CD4 count Diarhoea* 
 No < 2 
weeks 
> 2 
weeks Total 
< 200* 44 8 5 13 
> 200 76 4 4 8 
Total 120 12 9 21 
 P value < 0.0001               * significant            
 Cryptosporidiosis was significantly more in those with CD4 count 
below 200 thereby indicating the susceptability of cryptosporidiosis increases 
significantly more when CD4 count is below 200. 
 The mean CD4 around which the cryptosporidiosis present with 
diarrhoea is 192.10.  (S.D. 135.03). 
Table 13: Distribution of Ehistotlynca and CD4 count 
CD4 With diarhoea 
 No. < 2 weeks > 2 weeks T 
< 200 44 1 3 4 
> 200 76 6 6 12 
 120 7 9 16 
  
When the CD4 count and E. Histolytica was analysed E.Histolytica was 
significantly more among those whose CD4 count above 200. 
 
Table 14: Distribution of E.coli and CD4 
Diarrhoea  CD4 count 
Acute Chronic Total 
Non diarhoea 
< 200* 3 3 6 2 8 
> 200 2 4 6 1 7 
Total 5 7 12 3 15 
 
P value = 0.55818            * not significant 
 
 Distribution of E.coli and CD4 count were not significant. 
 
Distribution of cryptosporidiosis in relation to cases and control 
Table 15: Distribution of cryptosporidiosis in relation to cases and control 
Cryptospordium  With D Without D Control 
-ve 59 38 38 
+ve* 21 2 2 
Total 80 40 40 
 
P value = 0.00531  * significant 
 
Cryptosporidiosis statistically significant in diarrhoeal group when compared 
with non diarrhoeal. 
Distribution of E.Histolytica in cases and control 
 
Table 16: Distribution of E.Histolytica in cases and control 
E.Histo  With D Without D Control 
-ve 64 38 38 
+ve* 16 2 2 
Total 80 40 40 
 
P value = 0.03006  * significant 
 
 E.Histolytica statistically significant in diarrhoeal group when compared 
with non diarrhoeal group. 
DISCUSSION 
 
Intestinal parasitosis due to various organism were found among HIV 
positive population globally but the prevalence vary country to country, region 
to region.  The probable explanation offered were socio economic status, food 
habits, hygienic practices and health status of the individual. 
 
 The present study consists of 62 male patients and 58 female 
patients. Lack of gender difference may be due to inclusion of cases in view of 
rigid criteria adopted. 
 
 In present 
study most patients of HIV positive patients 73.6% were aged 20- 39 years 
showing preponderance of infection with sexually active age group, this causes 
great concern because morbidity and mortality in these age group reflects 
badly on health status of the Nation and loss of Human resources and when 
they die, leaving behind many orphans which will be a great burden to the 
society. 
 
 In present study, rural preponderance was observed. This reflects 
the type 4-pattern spread from Urban to Rural Areas; this is because the Rural 
People often traveling to Towns and Cities in searching of Jobs with increased 
level of ignorance and illiteracy among the Rural Population. 
                Of the male only 9.7% were illiterates but in female illiteracy 
among 26%, which highlights increasing the literacy rate may bring down 
the incidence of HIV infection. In this study the commonest mode of 
transmission of HIV were found to be Heterosexual. 
 
 Studies in India, indicated that Diarrhea has been the third 
common clinical presentation in HIV patients (Merchant& Sharoff 1988)-
Diarrhea is a cardinal symptoms of HIV infection, and is considered as AIDS 
defining condition (Mith&Jana1988) – In the present study HIV patients with 
Diarrhea accounts for 80/ 120 cases. 
 
 Opportunistic intestinal parasitic infection should be expected in  
HIV infected patients who presents with diarrhea (Viroj 2001)-In the present 
study, diarrhoea were noticed in 39 patients (32.50%) less than 2 weeks 
duration and those with > 2 weeks duration (34.20 %) 41 patients.   
 
 According to Okudua.M, et al distribution of intestinal parasitic 
infection among HIV infection subjects in Abeokuta Nigeria. Overall parasitic 
infection rate is 28.4%, According to Moroca, et al parasitic infection in HIV is 
45.5% and in Vinoj in Thailand the prevalence of intestinal parasitic among the 
patient is 50%   
 
 In the 
present study overall percentage of patients affected with intestinal parasites 
was 46.9% in HIV positive patient the percentage of patient affected with 
intestinal parasite is 46.7% 
 
 According to Javid et al their study showed that diarrhoea among  
the HIV infected group with    CD4 > 500 CELLS / mm3 was 14.7% and in 
group with 200-500 cells/mm3 , here were 29.8% and in HIV patients with 
CD4 <200 cells / mm3 this rate was 56% which was significantly compared 
with the former CD4 groups. Of the study, cryptosporodiasis were found in 
56.5% in the group of CD4 count <200 cells /mm3  
 
 Among those with E.coli , 28.9% were found to have  CD4 count 
<200 cells /mm3 and 17.4% in the group of 200-500 cells / mm3 and  20% 
in the group of CD4 count >500 cells/ mm3. 
 
 According to Mora et al, 45.5% patient had one or other 
intestinal parasites. Among them 48 patient (12.77%) had E.histolytica, E.coli 
were found is 46 patient (12.23%) giardia (10.3%) 3 a patient, 
cryptosporodium were found in 11 patient (3%). There is significant 
correlation between cryptosporodiasis and diarrhoea and CD4. 
 
 According to Minta et al,  46.7% of them had intestinal parasites 
among the HIV groups. Cryptosporodium were found 26.7%, the E.Coli in 
17.4%, Blastosis hominis in 8% ,E.nana in (7%) isopora belli in (7%) mixed 
were 10 cases. 
  According 
to Ebba Abate et al, cryptosporodiasis were found among 17 % of HIV patient. 
Isospora were present among 2% and mixed were 38% cryptosporodium were 
significantly associated with HIV positive cases37. 
 
 According 
to Brandonsior.O et al of the 51 HIV patient presented with diarrhoea, 17 cases 
were cryptosporodium (33.3%). 
 
 Alejandro carabello et al, observed cryptosporodium were found 
in 22.8%, Ascaris  lumbricoides, in 14.2% hook worm in (6%) trichuris 
trichuria in (8.6%), isosporo belli in 2.9% in the HIV patient presented with 
diarrhoea. 
 
 According Kava Mohandas et al observed Cryptosporodium 
were found in 10.8% of which 92.3% were presented with diarrhea. 
 
 Mackenzie
, et al. observed the massive out break in milwakee of cryptosporidium 
infection transmitted through the public water supply, cryptosporodiasis can be 
acquired to any time during the course of HIV infection. Major morbidity and 
mortality occur almost exclusively in patients with CD4 count below 180 
cells/mm3 above this level spontaneous recovery occur. 
  Diarrhoea has been significantly associated with 
cryptosporodium, giardia and isospora (cemimerman et al 1999). According to 
reports from Chandigarh in India, the most common parasite associated with 
diarrhoea was cryptosporidium parvum. 75% AIDS patient who tested for 
intestinal parasites had diarrhoea (Mohandas et al 2002)41. 
 
Of the HIV positive patient total parasites detected were 75 (62.5%) 
and in HIV negative patient, the parasite detected were 16 (40%) which 
also implies parasites in HIV patient is more among HIV positive patient. 
 
In the present study the prevalence of intestinal parasites in HIV patient 
were 46.7% among them cryptosporidium was found in 19.2% followed by 
E.Histolytica 15%, E.coli 12.5%, Ascaris 7.5%, H.nana 0.8%, Giardiasis 4.2%, 
Ankylostoma 2.5% and isospora 0.8%. 
 
Hence cryptosporidium is mainly presented with diarrhoea, and of the 
parasite detected crypto spordium is the most common parasite detected in HIV 
patient and CD4 count was low in this study as in other studies. 
  
The relative risk for cryptospordiasis  is about 7.6 times higher in HIV 
positive patient when compared to non HIV patient. 
 
 The present study as well as published reports clearly revealed that AIDS 
patients are prone for diarrhoea and the commonest organism being, cryptosporidium 
and the source being water supply. 
  In view of that, these HIV patient irrespective of the diarrhoea status should 
be motivated for hygienic practices and constantly monitored for CD4 count.  If they 
develop diarrhoea  one should look for unusual organism carefully and they should be 
treated accurately. 
 
CONCLUSION 
 
1) Intestinal parasitosis was significantly more among HIV positive 
population. 
2) The prevalence of intestinal parasitosis among HIV positive status was 
47% (43). 
3) Cryptospordiosis was the most predominant  one among HIV positive 
patients and it was significantly more if CD4 cell counts was below 200 
cells/mm3. 
4) The prevalence of E.Histolytica was significantly more among those with 
CD4 cell counts more than 200 cells/mm3. 
5) All these patients hailed from low socio economic status. 
6) Their educational status, water supply system, hand washing habits were 
suboptimal. 
 
SUMMARY 
 
Socio economic conditions, educational status and unhygienic practices 
contribute for intestinal parasitosis.  Since large number of HIV positive 
population belong to below poverty line, an attempt was made to study 
intestinal parasitosis among HIV positive population. 
 
 A total of 120 (M = 62, F = 58, Mean age = 35.28) HIV positive adults who 
satisfied a rigid selection criteria were screened for associated intestinal parasitosis 
and diarrhoea  40 healthy HIV negative non diarrhoeal population (age & sex 
matched) were kept as control.  They were subjected to sociodemographic, clinical 
and laboratory evaluation. 
 
 Intestinal parasitosis were significantly more among HIV positive patient and 
the prevalence was 46.7% (43).   
 
 Among the parasitosis cryptosporidosis dominated 19.2% (23) followed by 
E.Histolytica 15.0% (18), E.coli 12.5% (15), Ascaris 7.5% (9),                H.nana 0.8% 
(1), Giardiasis 4.2% (5), Ankylostoma 2.5% (3),                        Isospora 0.8% (1). 
 
 Cryptosporidiosis was found significantly more in those with CD4 counts  less 
than 200/mm3 thus indicating their susceptibility of cryptosporidiosis when CD4 
counts is lower.  
 E.Histolytica was found significantly more among those with CD4 cell counts 
more than 200/mm3. 
  Since the hygienic environment and hygienic  practice far from satisfactory all 
of them were educated to adopt hygienic practice.  It is suggested that to have routine 
evaluation of AIDS cases with diarrhoea for common and uncommon pathogen in 
order to provide appropriate therapeutic measures.  
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MASTER CHART 
              
Sl. No.  Age Sex R/U Ht (cm) Wt (Kgs) BMI CD4 CD8 Ratio Wet.Saline Wet.Iodine  Floatation  Formol     
ethersaline 
1 45 M U 151 41 17.98 389 1815 0.21         
2 28 F R 149 58 26.12 452 1299 0.35         
3 24 M R 151 44 19.3 159 697 0.23   E.C   E.C 
4 42 M U 159 40 15.82 176 631 0.28         
5 32 M R 154 41 17.28 332 1005 0.33         
6 35 F U 168 49 17.36 37 612 0.06         
7 29 F R 161 35 13.55 76 799 0.1         
8 40 F U 165 59 21.67 428 2000 0.21   E.C E.C   
9 35 M R 158 39 15.62 120 796 0.15         
10 30 M R 159 36 14.24 172 516 0.31         
11 51 M R 157 32 12.98 433 894 0.48         
12 42 F U 162 57 21.72 123 656 0.19         
13 36 M R 167 64 22.95 256 778 0.32         
14 21 F R 151 39 17.1 235 1457 0.16 E.H       
15 35 M U 164 40 14.87 204 1127 0.18   E.C, E.H     
16 32 F R 147 59 27.3 101 650 0.13         
17 39 M R 158 32 12.82 225 989 0.22       E.H 
18 36 M U 157 41 16.63 224 490 0.05       G 
19 26 F U 161 40 14.34 433 894 0.48         
20 22 F R 156 44 18.08 233 1318 0.18         
21 33 M U 151 40 17.54 38 145 0.26 E.H E.H     
22 30 M R 158 34 13.62 219 962 0.23         
23 33 M R 154 41 17.29 328 1841 0.28         
24 52 F U 151 46 20.18 309 2000 0.15         
25 35 F R 154 37 15.6 311 798 0.32         
26 33 M U 156 36 14.79 350 2000 0.17   E.C     
27 25 M R 142 46 22.81 721 1290 0.56         
28 25 F U 148 53 24.2 252 1191 0.21         
29 24 M U 168 44 15.6 489 1330 0.37       G 
30 32 M R 172 50 16.9 120 796 0.15         
31 34 F R 154 31 13.07 174 1405 0.12 E.H       
32 31 F U 160 38 14.84 148 407 0.41       H.N 
33 42 F R 152 57 24.67 171 1673 0.1   E.C E.C   
34 34 F R 156 34 13.97 82 1165 0.07 E.H E.H     
35 52 M U 145 45 21.4 120 796 0.15         
36 31 F R 156 36 14.8 172 560 0.31   E.C     
37 53 M R 163 48 18.07 291 864 0.34       E.H 
38 32 F R 148 57 26.02 292 798 0.37         
39 51 F U 154 43 18.13 36 480 0.08         
40 32 M R 163 44 16.6 212 634 0.33         
41 51 F R 145 42 19.97 202 720 0.3 E.H       
42 31 F U 149 40 18.01 195 2020 0.1         
43 21 F R 148 29 13.23 694 2080 0.35 E.H E.H/ A.L   E.C/AL
44 22 F U 150 43 19.11 830 936 0.89   E.H   E.H 
45 20 F R 152 36 15.58 315 1858 0.17       E.H 
46 44 M U 157 41 16.63 196 640 0.31     E.C   
47 30 M R 171 48 16.42 180 1200 0.15         
48 54 F R 153 44 18.8 128 1496 0.09       ANKY 
49 33 M R 148 29 13.23 34 306 0.11         
50 51 M U 166 37 13.43 82 1165 0.07         
51 44 M R 155 34 14.15 281 883 0.33         
52 31 F R 167 36 12.9 84 1284 0.07         
53 35 F U 157 35 15.01 165 781 0.21   AL   AL 
54 32 M U 154 35 14.75 532 1320 0.04   E.H   E.H 
55 34 F R 170 36 12.45 197 458 0.43   AL   AL 
56 32 M R 154 35 15.15 514 2000 0.26   E.H E.C E.H 
57 34 F R 161 37 14.27 104 379 0.27         
58 28 F U 148 23 10.5 46 786 0.06         
59 32 M R 172 50 16.9 356 815 0.44         
60 34 M U 164 54 20.01 602 1366 0.44         
61 30 F R 161 35 13.5 114 608 0.19   AL   AL 
62 27 M R 157 46 18.66 198 407 0.49         
63 43 F R 152 40 17.31 579 1179 0.49   E.H   E.H 
64 38 M R 164 36 13.38 335 586 0.58         
65 36 F R 148 34 15.52 47 426 0.11   E.C   E.C 
66 40 M R 162 42 16 881 1435 0.61       E.H 
67 32 M U 163 36 18.54 330 742 0.44   AL   AL 
68 30 F U 161 36 13.88 253 1895 0.13         
69 33 M R 163 39 14.67 183 925 0.02   E.H   E.H/G 
70 44 M R 160 45 17.57 204 1280 0.19         
71 51 F R 153 47 20.08 28 358 0.07         
72 32 M U 170 51 17.05 180 736 0.24   AL   AL 
73 47 M R 158 41 16.42 204 1227 0.18         
74 25 F R 156 36 14.79 508 736 0.69   E.H/E.C   E.H/E.C
75 43 F U 150 42 18.67 87 1046 0.08         
76 27 F R 147 33 15.27 37 768 0.05   E.C   E.C 
77 30 F U 152 44 18.04 179 562 0.31       ANKY 
78 43 M R 165 36 13.22 198 962 0.21         
79 27 M U 166 37 13.43 68 421 0.16         
80 25 M R 163 47 17.69 112 566 0.22         
81 21 M U 161 34 14.36 198 523 0.38         
82 40 F U 153 36 13.37 152 821 0.19         
83 31 M U 163 41 15.43 186 964 0.19         
84 34 M R 168 49 29.17 120 730 0.16 E.C E.C E.C E.C 
85 39 F R 155 33 13.73 263 938 0.28         
86 23 M R 176 56 18.08 614 1768 0.35         
87 42 M R 160 45 17.58 149 1666 0.09         
88 29 F U 145 36 17.12 52 391 0.13         
89 37 F R 151 31 13.06 196 460 0.46         
90 35 M R 162 44 16.77 204 642 0.32         
91 29 M U 161 40 15.43 71 560 0.13   E.C   E.C 
92 36 M R 154 52 21.93 393 >2000 >0.20         
93 27 F R 163 39 14.7 281 863 0.33         
94 34 F U 151 38 16.67 830 936 0.89         
95 26 M U 163 39 14.7 243 1215 0.2         
96 42 F R 152 35 15.15 146 1730 0.08         
97 37 M R 154 39 16.45 74 773 0.1         
98 33 F U 148 57 26.02 378 <2000 >0.19 E.H E.H   E.H
99 51 F R 150 46 20.44 793 1039 0.76         
100 24 M U 166 40 14.52 82 1165 0.07       ANKY 
101 24 F R 151 34 14.91 830 936 0.89         
102 38 M R 168 49 17.36 44 660 0.06         
103 33 F U 154 39 16.45 281 863 0.33   E.H   E.H 
104 42 F R 146 52 24.4 216 1583 0.14       ASCARIS 
105 23 M R 163 47 17.7 76 799 0.1         
106 43 M R 157 39 15.82 792 1215 0.65         
107 23 F U 155 35 15.05 204 1127 0.18         
108 51 F R 152 42 18.18 256 1585 0.16         
109 57 M U 170 42 14.53 42 428 0.1         
110 44 M R 167 52 18.65 553 1760 0.03   E.C     
111 22 F U 146 42 19.7 436 1522 0.28         
112 34 M R 161 44 16.98 64 1029 0.06       ASCARIS
113 32 F U 149 43 19.39 210 8020 0.26         
114 49 M U 160 38 14.84 286 937 0.3         
115 53 F U 156 43 17.67 194 1236 0.16         
116 51 M R 158 45 18.03 36 572 0.06         
117 31 F R 154 41 17.29 291 864 0.34       ASCARIS
118 32 M R 166 43 15.6 252 1191 0.21         
119 57 M R 169 44 15.41 311 978 0.32       G 
120 35 F U 148 39 17.81 526 1840 0.28       G 
121 41 M R 162 71 27.1       
  
    
  
122 24 F U 151 38 16.7       E.COLI     E.COLI
123 33 F R 153 49 20.9               
124 26 M U 161 59 21.6               
125 31 M U 171 74 25.3             GIARD
126 39 M U 163 59 22.21               
127 23 F U 157 61 24.75               
128 26 M U 169 72 20.21               
129 34 F R 162 63 28.38               
130 33 F U 152 57 24.67               
131 51 F R 154 73 30.74       E.COLI     E.COLI
132 21 F U 149 43 19.37               
133 23 M U 162 45 17.1               
134 24 F R 155 49 20.4               
135 29 F U 149 44 19.8               
136 21 M R 167 52 18.65       E.HISTO E.HIST   E.HIST
137 34 F R 143 48 23.43               
138 25 M U 162 57 21.72             ASCARIS
139 21 F U 159 69 27.89               
140 37 M R 169 78 27.31       E.COLI     E.COLI
141 26 F R 148 45 20.5               
142 23 M U 165 60 22.04               
143 33 F U 152 55 23.81             ANKYLO
144 37 M U 171 82 28.04               
145 42 F R 162 80 33.05               
146 33 M U 165 86 31.59               
147 43 M R 171 92 31.46               
148 52 M U 177 89 28.4               
149 41 F R 148 50 29.3               
150 41 M R 168 77 27.28             GIARDI
151 34 F U 172 74 25.01               
152 43 F U 161 69 26.62       E.COLI     E.COLI
153 29 F U 1174 82 27.08               
154 49 M R 173 90 30.07               
155 37 M R 147 49 22.35               
156 33 F U 152 61 25.72             GIARDI
157 36 M U 177 86 27.45               
158 49 F U 161 73 28.16             ASCARIS
159 37 M R 154 52 29.93             E.HISTO
160 32 F R 167 68 25.28             H.NANA
 

PROFORMA 
(Prevalence of intestinal parasites in HIV infection) 
 
Name   : 
Age   : 
Sex   : Male  / Female 
ID No.  : 
Ward No.  : 
Education status : 
Marital Status : Single / Married / Separated  
Occupation  : 
Domiciline   : Rural / Urban 
Behaviour  : Promiscuity / Previous STD 
 
CF: 
Complaints and duration: 
H/o treatment taken   : Yes / No 
H/o needle prick   : Yes / No 
Vitals: 
PR :    Ht  : 
BP :    Wt. : 
R.R. :    BMI : 
Temp.   : 
CVS   : 
Rs.   : 
Abdomen   : 
CNS   : 
Investigation: 
 Positive   Negative 
First Elisa   
Second Elisa   
  
CD4 count  : 
CD8 count  : 
CD4 / CD8 ratio : 
Motion Examination:   Cry    Ec    Eh    Asc  Iso   H.n  Ank    others 
1) Wet I2 method 
2) Wet Saline method 
3) Floatation technique  
4) Formal ether saline 
5) Formal ether I2 
6) Modified AFS 
 
